14 Breast Cancer Clinical Trials in Ann Arbor, MI (2026)

Q: How do I join a clinical trial in Ann Arbor?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you.

Recruiting Breast Cancer Studies in Ann Arbor

NCT07211178Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

For patients with breast cancer, it's important to find any remaining cancer cells after they've had their main treatment. Even a few cells, called minimal residual disease (MRD), can lead to the canc...

Ann Arbor, MI900 participantsTempus AI

View Study Details

NCT05715255Recruiting

Adaptive Symptom Self-Management Immunotherapy Study

The use of immune checkpoint inhibitors (ICIs), alone or in combination with other cancer treatments is increasing dramatically with immune-related adverse events (irAEs) common (90%) during ICI treat...

Ann Arbor, MINA400 participantsUniversity of Arizona

View Study Details

NCT06253871Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with advanced cancers that...

Ann Arbor, MIPHASE1383 participantsIambic Therapeutics, Inc

View Study Details

NCT05379153Recruiting

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

This phase III trial tests whether vaginal fractional CO2 laser therapy works in treating vaginal dryness in breast cancer survivors. Vaginal dryness can be commonly experienced with normal aging, wit...

Ann Arbor, MIPHASE3250 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT05467891Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

This is an open label, multicenter, single arm phase II study to evaluate the efficacy and safety of ribociclib and ET in patients with locoregional recurrence of HR-positive, HER2-negative breast can...

Ann Arbor, MIPHASE2200 participantsOana Danciu

View Study Details

NCT06184750Recruiting

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Increasing breast density is a well establi...

Ann Arbor, MIPHASE2200 participantsNational Cancer Institute (NCI)

View Study Details

NCT07291414Recruiting

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients r...

Ann Arbor, MINA80 participantsUniversity of Michigan Rogel Cancer Center

View Study Details

NCT07158021Recruiting

Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

This phase II trial compares leuprolide to goserelin for reducing estrogen production by the ovaries in pre- or peri-menopausal women with breast cancer. Estrogen can cause the growth of breast cancer...

Ann Arbor, MIPHASE275 participantsUniversity of Michigan Rogel Cancer Center

View Study Details

NCT06100263Recruiting

Breast Cancer Resiliency Through Exercise Program (B-REP)

The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-interve...

Ann Arbor, MINA75 participantsUniversity of Michigan Rogel Cancer Center

View Study Details

NCT06195306Recruiting

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

This phase II trial evaluates tamoxifen, with or without omega-3 fatty acids, for reducing risk of breast cancer among postmenopausal and overweight or obese women who are at increased risk of develop...

Ann Arbor, MIPHASE266 participantsNational Cancer Institute (NCI)

View Study Details

NCT05996107Recruiting

Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer

The purpose of this research study is to determine the safety, tolerability and dose of Ribociclib when combined with adjuvant radiation in women with high-risk ER+ breast cancer. Once enrolled on st...

Ann Arbor, MIPHASE130 participantsUniversity of Michigan Rogel Cancer Center

View Study Details

NCT05183126Recruiting

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

The primary objective of this pharmacokinetics study is to compare the maximum concentration level of paclitaxel in patients with low/sarcopenic skeletal muscle area (SMA), at the end of a 2-3 hour pa...

Ann Arbor, MIPHASE422 participantsUniversity of Michigan Rogel Cancer Center

View Study Details

NCT06915168Recruiting

CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer

This clinical trial studies how well a chemotherapy-induced peripheral neuropathy (CIPN) decision aid works in improving chemotherapy decision making among patients with breast cancer. CIPN involves n...

Ann Arbor, MINA20 participantsUniversity of Michigan Rogel Cancer Center

View Study Details

NCT07443943Recruiting

A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial

This phase II trial tests the safety and effectiveness of a dietary supplement called resistant potato starch for reducing musculoskeletal symptoms in patients with stage 0-III breast cancer or who ar...

Ann Arbor, MIPHASE220 participantsUniversity of Michigan Rogel Cancer Center

View Study Details

About Breast Cancer Clinical Trials in Ann Arbor

Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.

There are currently 14 breast cancer clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 2,721 participants. Research is being sponsored by Tempus AI, University of Arizona, Iambic Therapeutics, Inc and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Breast Cancer Clinical Trials in Ann Arbor — FAQ

Are there breast cancer clinical trials in Ann Arbor?

Yes, there are 14 breast cancer clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ann Arbor?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.

Are clinical trials in Ann Arbor free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.

What breast cancer treatments are being tested?

The 14 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.

Data updated July 17, 2026 from ClinicalTrials.gov